[Percutaneous therapy of respiratory diseases].
D000085:Acetates; D001565:Benzoates / Q000627:therapeutic use*; D002164:Camphor / Q000627:therapeutic use*; D005100:Expectorants / Q000627:therapeutic use*; D006801:Humans; D009821:Oils / Q000627:therapeutic use*; D012120:Respiration Disorders; D012137:Respiratory System; D012140:Respiratory Tract Diseases; D012459:Salicylates
D000085:Acetates; D001565:Benzoates; D005100:Expectorants; D009821:Oils; D012459:Salicylates; D002164:Camphor
ACETIC ACID/derivatives; BENZOATES/therapeutic use; CAMPHOR/therapeutic use; EXPECTORANTS/therapeutic use; OILS/therapeutic use; RESPIRATORY TRACT/diseases; SALICYLIC ACID/derivatives
Beitrag zur perkutanen Therapie von Erkrankungen der Atmungsorgane.